Abstract:Muscle atrophy is a detrimental and injurious condition that leads to reduced skeletal muscle mass and disruption of protein metabolism. Oyster (Crassostrea nippona) is a famous and commonly consumed shellfish in East Asia and has become a popular dietary choice worldwide. The current investigation evaluated the efficacy of C. nippona against muscle atrophy, which has become a severe health issue. Mammalian skeletal muscles are primarily responsible for efficient metabolism, energy consumption, and body movements. The proteins that regulate muscle hypertrophy and atrophy are involved in muscle growth. C. nippona extracts were enzymatically hydrolyzed using alcalase (AOH), flavourzyme (FOH), and protamex (POH) to evaluate their efficacy in mitigating dexamethasone-induced muscle damage in C2C12 cells in vitro. AOH exhibited notable cell proliferative abilities, promoting dose-dependent myotube formation. These results were further solidified by protein expression analysis. Western blot and gene expression analysis via RT-qPCR demonstrated that AOH downregulated MuRF-1, Atrogin, Smad 2/3, and Foxo-3a, while upregulating myogenin, MyoD, myosin heavy chain expression, and mTOR, key components of the ubiquitin–proteasome and mTOR signaling pathways. Finally, this study suggests that AOH holds promise for alleviating dexamethasone-induced muscle atrophy in C2C12 cells in vitro, offering insights for developing functional foods targeting conditions akin to sarcopenia.

What problem does this paper attempt to address?

This paper aims to explore the potential of Japanese oyster (*Crassostrea nippona*) hydrolysate as a dietary supplement in alleviating dexamethasone - induced muscle atrophy. Specifically, the study evaluated the alleviating effects of Japanese oyster extracts hydrolyzed with three different enzymes (alkaline protease, flavourzyme, and protamex) on dexamethasone - induced muscle damage in C2C12 cells through in vitro experiments. ### Main research questions 1. **Evaluate the cytotoxicity of Japanese oyster hydrolysate**: The study first evaluated the cytotoxicity and proliferation ability of different concentrations of Japanese oyster hydrolysate on C2C12 cells. 2. **Explore the effect of Japanese oyster hydrolysate on muscle growth**: Through immunofluorescence staining and myotube diameter analysis, the study investigated the effect of Japanese oyster hydrolysate on myosin heavy chain (MyHC) expression and myotube diameter. 3. **Analyze the molecular mechanism of Japanese oyster hydrolysate**: Through Western blot and real - time quantitative polymerase chain reaction (RT - qPCR), the study investigated the effect of Japanese oyster hydrolysate on the expression of key myogenic markers (such as MyHC, myogenin, MyoD, mTOR) and muscle atrophy - related genes (such as MuRF - 1, Atrogin, Smad 2/3, Foxo - 3a). ### Key findings - **Cytotoxicity and proliferation**: The study found that alkaline protease hydrolysate (AOH) and protamex hydrolysate (POH) were non - toxic to C2C12 cells at concentrations of 25, 50, and 100 µg/mL, and significantly promoted cell proliferation. - **Myotube formation and MyHC expression**: C2C12 cells treated with AOH and POH showed a significant increase in myosin heavy chain (MyHC) expression and myotube diameter, indicating that these hydrolysates contribute to myotube formation. - **Protein and gene expression**: Western blot and RT - qPCR results showed that AOH significantly up - regulated the expression of MyHC, myogenin, MyoD, and mTOR, while down - regulating the expression of MuRF - 1, Atrogin, Smad 2/3, and Foxo - 3a, indicating that AOH alleviates muscle atrophy by regulating these key signaling pathways. ### Conclusion The results of this study indicate that Japanese oyster hydrolysate, especially alkaline protease hydrolysate (AOH), has significant potential in alleviating dexamethasone - induced muscle atrophy. These findings provide new ideas and scientific basis for the development of functional foods and the treatment of similar muscle atrophy diseases (such as sarcopenia).

Exploring the Potential of Crassostrea nippona Hydrolysates as Dietary Supplements for Mitigating Dexamethasone-Induced Muscle Atrophy in C2C12 Cells

Protective Role of Ethanol Extract of Cibotium barometz (Cibotium Rhizome) against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotubes

The Effects of Omega-3 Fatty Acid Supplementation on Dexamethasone-Induced Muscle Atrophy

Preventive Effects of Collagen-Derived Dipeptide Prolyl-Hydroxyproline against Dexamethasone-Induced Muscle Atrophy in Mouse C2C12 Skeletal Myotubes

Ginsenosides Rh1, Rg2, and Rg3 ameliorate dexamethasone-induced muscle atrophy in C2C12 myotubes

Laurel Attenuates Dexamethasone-Induced Skeletal Muscle Atrophy in Vitro and in a Rat Model

β–Hydroxy β–Methylbutyrate Improves Dexamethasone-Induced Muscle Atrophy by Modulating the Muscle Degradation Pathway in SD Rat

β-Sitosterol Attenuates Dexamethasone-Induced Muscle Atrophy via Regulating FoxO1-Dependent Signaling in C2C12 Cell and Mice Model

Attenuation of Skeletal Muscle Atrophy Induced by Dexamethasone in Rats by Teaghrelin Supplementation

Diphlorethohydroxycarmalol Derived from Ishige okamurae Improves Behavioral and Physiological Responses of Muscle Atrophy Induced by Dexamethasone in an In-Vivo Model

The Preventive Effect of Specific Collagen Peptides against Dexamethasone-Induced Muscle Atrophy in Mice

Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model

Cornflower Extract and Its Active Components Alleviate Dexamethasone-Induced Muscle Wasting by Targeting Cannabinoid Receptors and Modulating Gut Microbiota

Identification of Peucedanum japonicum Thunb. extract components and their protective effects against dexamethasone-induced muscle atrophy

Preventive Effects of Schisandrin A, A Bioactive Component of Schisandra chinensis, on Dexamethasone-Induced Muscle Atrophy

The Extract of Gloiopeltis tenax Enhances Myogenesis and Alleviates Dexamethasone-Induced Muscle Atrophy

Muscle-Protective Effect of Carnosine against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotube

Beef peptides mitigate skeletal muscle atrophy in C2C12 myotubes through protein degradation, protein synthesis, and oxidative stress pathway

6'-sialyllactose prevents dexamethasone-induced muscle atrophy by controlling the muscle protein degradation pathway

Theophylline Prevents Dexamethasone-Induced Atrophy in C2C12 Myotubes

Potential of Lycii Radicis Cortex as an Ameliorative Agent for Skeletal Muscle Atrophy